Can people with prostate cancer eat beef?

Written by Liu Liang
Oncology
Updated on January 08, 2025
00:00
00:00

Patients with prostate cancer can eat beef. Beef is a high-protein food, and as cancer is a consumptive disease, it is generally advised to enhance nutrition in the diet, such as meats, proteins, vegetables, and fruits to maintain a balanced diet with both meat and vegetables. Avoid junk food, such as pickled vegetables from pickled jars, barbecue items, or excessively oily foods with high fat content. Those should be avoided as much as possible, but other foods, including beef, can be consumed.

Other Voices

doctor image
home-news-image
Written by Yan Chun
Oncology
56sec home-news-image

Is vomiting in prostate cancer due to metastasis to the liver?

Patients with prostate cancer may experience vomiting due to the metastasis of the disease to the liver, causing damage to liver function. However, vomiting could also be caused by other reasons, such as the metastasis of prostate cancer to the peritoneum of the abdominal cavity. Clinically, this can lead to cancerous intestinal obstruction, with symptoms commonly including vomiting, abdominal pain, bloating, reduced bowel movements and gas, or cessation of bowel movements and gas. When prostate cancer metastasizes to the brain, the increased intracranial pressure can also cause symptoms such as vomiting, headache, swelling of the optic disc, hemiplegia, and aphasia. Additionally, some prostate cancer patients may experience vomiting due to toxic side effects from treatments such as chemotherapy and targeted therapy.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
43sec home-news-image

Where can prostate cancer metastasize to?

When prostate cancer invades surrounding tissues and structures, it can cause a variety of clinical symptoms, including urinary irritation, urinary obstruction, urinary incontinence, sciatica, erectile dysfunction, etc., and can compress causing unilateral or bilateral hydronephrosis. In severe cases, when the tumor invades the rectum, it can cause difficulty in defecation or colon obstruction. When the cancer metastasizes to the bones, it can cause bone pain and pathological fractures, and may also spread to the lungs.

doctor image
home-news-image
Written by Liu Liang
Oncology
50sec home-news-image

Is chemotherapy for prostate cancer painful?

For patients with advanced prostate cancer, endocrine therapy is primarily used. Chemotherapy is generally chosen when endocrine therapy is resistant and ineffective. The side effects of chemotherapy are similar to those of other chemotherapy treatments. The first is the gastrointestinal side effects, such as nausea, vomiting, decreased appetite, or bloating and abdominal pain. The second is bone marrow suppression, which leads to a decrease in white blood cells and platelets. The side effects of chemotherapy vary with each patient's constitution and other factors. In most cases, with the support of medications for stomach protection, anti-nausea, and increasing white blood cells, the majority of patients can generally tolerate the treatment.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
40sec home-news-image

androgen deprivation therapy for prostate cancer

Androgen deprivation therapy for prostate cancer includes surgical castration, which can quickly and continuously reduce levels to very low levels. The second is medical castration, which involves the use of analogs of luteinizing hormone-releasing hormone. Currently available products include leuprolide, goserelin, and triptorelin. Third, estrogen therapy, with diethylstilbestrol being the most common estrogen treatment. Surgical castration, medical castration, or estrogen therapy offer similar progression-free survival rates in patients with tumor-related outcomes.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 9sec home-news-image

Will prostate cancer embryonic antigen rise?

Prostate cancer is a common malignant tumor in the male urinary system. In some patients with prostate issues, there may be an increase in the carcinoembryonic antigen index in blood tests, but not all patients will exhibit this marker increase. Most prostate cancer patients will show an increase in the prostate-specific antigen (PSA) in blood tests, or there may be abnormal ratios of free PSA to bound PSA. Carcinoembryonic antigen and prostate-specific antigen are tumor markers for prostate cancer, but they only provide auxiliary value for diagnosis and do have some evaluative value regarding the effectiveness of anti-tumor treatment. Additionally, they can serve as a monitor for the condition of prostate cancer. Clinically, to confirm a diagnosis of prostate cancer, it is necessary to rely on the results of pathological tissue obtained through biopsy.